⚠️ This provider averages 924 services per working day — physically unusual for an individual practitioner
Based on 2.3M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $33.2M in total Medicare payments ranks in the 99th percentile of Rheumatology providers nationally.
Averaging 924 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $27.09 | $15.67 | 1.73x | $11.42 | $2.2M | 137.9K | 28 |
| 2015 | $34.33 | $19.72 | 1.74x | $14.61 | $2.9M | 144.9K | 41 |
| 2016 | $27.90 | $16.15 | 1.73x | $11.75 | $3.9M | 241.4K | 36 |
| 2017 | $25.90 | $15.48 | 1.67x | $10.42 | $3.4M | 222.7K | 37 |
| 2018 | $21.23 | $13.12 | 1.62x | $8.11 | $4.5M | 346.2K | 42 |
| 2019 | $25.93 | $15.51 | 1.67x | $10.42 | $4.0M | 260.5K | 36 |
| 2020 | $23.69 | $13.41 | 1.77x | $10.28 | $3.2M | 235.1K | 33 |
| 2021 | $25.95 | $13.76 | 1.89x | $12.19 | $3.0M | 220.3K | 33 |
| 2022 | $24.62 | $12.22 | 2.01x | $12.40 | $3.1M | 250.6K | 36 |
| 2023 | $24.91 | $11.88 | 2.10x | $13.03 | $3.0M | 250.8K | 36 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 179.3K | $9.6M | $53.72 | 1.78x |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 146.7K | $5.3M | $35.87 | 1.59x |
| J3262 | Injection, tocilizumab, 1 mg | 1.2M | $4.1M | $3.45 | 1.47x |
| J0897 | Injection, denosumab, 1 mg | 164.2K | $2.5M | $15.02 | 1.36x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 25.7K | $2.3M | $90.15 | 1.47x |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 141.2K | $2.2M | $15.30 | 1.96x |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 258.0K | $1.4M | $5.31 | 1.60x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 10.6K | $1.2M | $117.14 | 2.13x |
| 20610 | Aspiration and/or injection of fluid from large joint | 11.7K | $686.6K | $58.50 | 3.16x |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 10.1K | $655.0K | $64.77 | 1.54x |
| J9310 | Injection, rituximab, 100 mg | 1.1K | $647.8K | $599.29 | 1.34x |
| J9312 | Injection, rituximab, 10 mg | 5.1K | $379.5K | $74.42 | 1.28x |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 27.9K | $361.5K | $12.95 | 2.07x |
| 96415 | Administration of chemotherapy into vein, each additional hour | 13.0K | $319.8K | $24.66 | 4.06x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 2.5K | $165.1K | $64.98 | 1.60x |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 13.5K | $132.6K | $9.82 | 2.04x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 892 | $118.4K | $132.74 | 1.51x |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | 2.3K | $106.2K | $45.29 | 4.42x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 1.7K | $103.2K | $61.59 | 4.06x |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 1.4K | $94.2K | $68.21 | 2.57x |
This provider submits charges 1.78 times higher than what Medicare actually pays.
A markup ratio of 1.78x means for every $100 Medicare pays, this provider initially charges $178. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Rheumatology providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Stephen Soloway, M.D.,FACP.,FACR.,CCD | Vineland, NJ | $42.7M | ✓ Clear |
| Steven Golombek, M.D. | Dover, NJ | $34.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data